Skip to Main Content

Paper Details

A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma.
Eur Urol
40
2021
Metastatic Renal Cell Carcinoma, NivoIpi, PATIENT, Pembrolizumab, atezolizumab, axitinib, bevacizumab, cabozantinib, ipilimumab, mRCC, metastatic kidney cancer, metastatic renal cell carcinoma, nivolumab, patient, patients, tyrosine, tyrosine kinase
Artificial Intelligence, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Male, Network Meta-Analysis, Nivolumab
Author NameAffiliation
Irbaz Bin RiazMayo Clinic
Huan HeMayo Clinic
Alexander J RyuMayo Clinic
Rabbia SiddiqiDow University of Health Sciences
Syed Arsalan Ahmed NaqviDow University of Health Sciences
Yuanqing YaoTsinghua University
Muhammad HusnainBanner University Medical Center, University of Arizona
Deepa Maheswari NarasimhuluMayo Clinic
Jessey MathewMayo Clinic
Qurat Ul Ain Riaz SipraBanner University Medical Center, University of Arizona
Per Olav VandvikUniversity of Oslo
Richard W JosephMayo Clinic
Hongfang LiuMayo Clinic
Zhen WangMayo Clinic
Vitaly HerasevichMayo Clinic
Parminder SinghMayo Clinic
Syed A HussainUniversity of Sheffield Medical School
Thai H HoMayo Clinic
Alan H BryceMayo Clinic
Lance C PagliaroMayo Clinic
Mohammad Hassan MuradMayo Clinic
Mohammad Hassan MuradMayo Clinic
Brian A CostelloMayo Clinic
  • 1 - 23

Datasets

Release 1.2